Vepacel Europese Unie - Bulgaars - EMA (European Medicines Agency)

vepacel

ology bioservices ireland ltd - Грипният вирус (иниактивиран цял вирион), съдържащ антиген от: a / vietnam / 1203/2004 (h5n1) - influenza, human; immunization; disease outbreaks - Грипни ваксини - Активна имунизация срещу подтип h5n1 на грипния вирус А.. Тази справка се основава на имуногенност на данни от доброволци на възраст от 6 месеца и повече след въвеждането на две дози от ваксината, приготвени с щамове на подтип h5n1 . vepacel трябва да се използва в съответствие с официалните насоки.

Celdoxome pegylated liposomal Europese Unie - Bulgaars - EMA (European Medicines Agency)

celdoxome pegylated liposomal

yes pharmaceutical development services gmbh - доксорубицин хидрохлорид - breast neoplasms; ovarian neoplasms; multiple myeloma; sarcoma, kaposi - Антинеопластични средства - celdoxome pegylated liposomal is indicated in adults:as monotherapy for patients with metastatic breast cancer, where there is an increased cardiac risk. or treatment of advanced ovarian cancer in women who have failed a first-line platinum-based chemotherapy regimen. in combination with bortezomib for the treatment of progressive multiple myeloma in patients who have received at least one prior therapy and who have already undergone or are unsuitable for bone marrow transplant. for treatment of aids-related kaposi’s sarcoma (ks) in patients with low cd4 counts (< 200 cd4 lymphocytes/mm3) and extensive mucocutaneous or visceral disease. celdoxome pegylated liposomal may be used as first-line systemic chemotherapy, or as second line chemotherapy in aids-ks patients with disease that has progressed with, or in patients intolerant to, prior combination systemic chemotherapy comprising at least two of the following agents: a vinca alkaloid, bleomycin and standard doxorubicin (or other anthracycline).

Celvapan Europese Unie - Bulgaars - EMA (European Medicines Agency)

celvapan

nanotherapeutics bohumil, s.r.o. - whole virion influenza vaccine, inactivated containing antigen of strain a/california/07/2009 (h1n1)v - disease outbreaks; influenza, human; immunization - Ваксини - Профилактика на грип, причинена от вируса a (h1n1) v 2009. celvapan трябва да се използва в съответствие с официалните насоки.

Kimmtrak Europese Unie - Bulgaars - EMA (European Medicines Agency)

kimmtrak

immunocore ireland limited - tebentafusp - uveal neoplasms - Антинеопластични средства - kimmtrak is indicated as monotherapy for the treatment of human leukocyte antigen (hla)-a*02:01-positive adult patients with unresectable or metastatic uveal melanoma.